147 related articles for article (PubMed ID: 28493277)
1. Bone mineral density in complete androgen insensitivity syndrome and the timing of gonadectomy.
King TFJ; Wat WZM; Creighton SM; Conway GS
Clin Endocrinol (Oxf); 2017 Aug; 87(2):136-140. PubMed ID: 28493277
[TBL] [Abstract][Full Text] [Related]
2. Height and bone mineral density in androgen insensitivity syndrome with mutations in the androgen receptor gene.
Danilovic DL; Correa PH; Costa EM; Melo KF; Mendonca BB; Arnhold IJ
Osteoporos Int; 2007 Mar; 18(3):369-74. PubMed ID: 17077943
[TBL] [Abstract][Full Text] [Related]
3. Case Report: Low Bone and Normal Lean Mass in Adolescents With Complete Androgen Insensitivity Syndrome.
Misakian A; McLoughlin M; Pyle LC; Kolon TF; Kelly A; Vogiatzi MG
Front Endocrinol (Lausanne); 2021; 12():727131. PubMed ID: 34526969
[TBL] [Abstract][Full Text] [Related]
4. Comparison of bone mineral density and body proportions between women with complete androgen insensitivity syndrome and women with gonadal dysgenesis.
Han TS; Goswami D; Trikudanathan S; Creighton SM; Conway GS
Eur J Endocrinol; 2008 Aug; 159(2):179-85. PubMed ID: 18463105
[TBL] [Abstract][Full Text] [Related]
5. Altered bone mineral density in patients with complete androgen insensitivity syndrome.
Bertelloni S; Baroncelli GI; Federico G; Cappa M; Lala R; Saggese G
Horm Res; 1998; 50(6):309-14. PubMed ID: 9973670
[TBL] [Abstract][Full Text] [Related]
6. Bone mineral density in the complete androgen insensitivity and 5alpha-reductase-2 deficiency syndromes.
Sobel V; Schwartz B; Zhu YS; Cordero JJ; Imperato-McGinley J
J Clin Endocrinol Metab; 2006 Aug; 91(8):3017-23. PubMed ID: 16735493
[TBL] [Abstract][Full Text] [Related]
7. [Study of bone mineral density in complete androgen insensitivity syndrome patients].
Tian QJ; Dai ZQ; Yu W; Tian JP; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2005 Dec; 40(12):799-802. PubMed ID: 16412322
[TBL] [Abstract][Full Text] [Related]
8. Bone Mineral Density in Transgender Individuals After Gonadectomy and Long-Term Gender-Affirming Hormonal Treatment.
Dobrolińska M; van der Tuuk K; Vink P; van den Berg M; Schuringa A; Monroy-Gonzalez AG; García DV; Schultz WCMW; Slart RHJA
J Sex Med; 2019 Sep; 16(9):1469-1477. PubMed ID: 31326306
[TBL] [Abstract][Full Text] [Related]
9. Bone Mineral Density in Women Living with Complete Androgen Insensitivity Syndrome and Intact Testes or Removed Gonads.
Bertelloni S; Meriggiola MC; Dati E; Balsamo A; Baroncelli GI
Sex Dev; 2017; 11(4):182-189. PubMed ID: 28715798
[TBL] [Abstract][Full Text] [Related]
10. Frequency of gonadal tumours in complete androgen insensitivity syndrome (CAIS): A retrospective case-series analysis.
Chaudhry S; Tadokoro-Cuccaro R; Hannema SE; Acerini CL; Hughes IA
J Pediatr Urol; 2017 Oct; 13(5):498.e1-498.e6. PubMed ID: 28351649
[TBL] [Abstract][Full Text] [Related]
11. The contribution of testosterone to skeletal development and maintenance: lessons from the androgen insensitivity syndrome.
Marcus R; Leary D; Schneider DL; Shane E; Favus M; Quigley CA
J Clin Endocrinol Metab; 2000 Mar; 85(3):1032-7. PubMed ID: 10720035
[TBL] [Abstract][Full Text] [Related]
12. Bone mineral density, body composition and metabolic profiles in adult women with complete androgen insensitivity syndrome and removed gonads using oral or transdermal estrogens.
Gava G; Mancini I; Orsili I; Bertelloni S; Alvisi S; Seracchioli R; Meriggiola MC
Eur J Endocrinol; 2019 Dec; 181(6):711-718. PubMed ID: 31491747
[TBL] [Abstract][Full Text] [Related]
13. Oestrogen versus androgen in hormone-replacement therapy for complete androgen insensitivity syndrome: a multicentre, randomised, double-dummy, double-blind crossover trial.
Birnbaum W; Marshall L; Werner R; Kulle A; Holterhus PM; Rall K; Köhler B; Richter-Unruh A; Hartmann MF; Wudy SA; Auer MK; Lux A; Kropf S; Hiort O
Lancet Diabetes Endocrinol; 2018 Oct; 6(10):771-780. PubMed ID: 30075954
[TBL] [Abstract][Full Text] [Related]
14. Changes in bone mineral density after orchidectomy and hormone replacement therapy in individuals with androgen insensitivity syndrome.
Mizunuma H; Soda M; Okano H; Kagami I; Miyamoto S; Ohsawa M; Ibuki Y
Hum Reprod; 1998 Oct; 13(1O):2816-8. PubMed ID: 9804237
[TBL] [Abstract][Full Text] [Related]
15. Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing's syndrome.
Minetto M; Reimondo G; Osella G; Ventura M; Angeli A; Terzolo M
Osteoporos Int; 2004 Nov; 15(11):855-61. PubMed ID: 15034643
[TBL] [Abstract][Full Text] [Related]
16. Pattern of bone mineral density in patients with sporadic idiopathic hypoparathyroidism.
Laway BA; Goswami R; Singh N; Gupta N; Seith A
Clin Endocrinol (Oxf); 2006 Apr; 64(4):405-9. PubMed ID: 16584512
[TBL] [Abstract][Full Text] [Related]
17. Management of Gonads in Adults with Androgen Insensitivity: An International Survey.
Tack LJW; Maris E; Looijenga LHJ; Hannema SE; Audi L; Köhler B; Holterhus PM; Riedl S; Wisniewski A; Flück CE; Davies JH; T'Sjoen G; Lucas-Herald AK; Evliyaoglu O; Krone N; Iotova V; Marginean O; Balsamo A; Verkauskas G; Weintrob N; Ellaithi M; Nordenström A; Verrijn Stuart A; Kluivers KB; Wolffenbuttel KP; Ahmed SF; Cools M
Horm Res Paediatr; 2018; 90(4):236-246. PubMed ID: 30336477
[TBL] [Abstract][Full Text] [Related]
18. Gonadectomy in Complete Androgen Insensitivity Syndrome: Why and When?
Döhnert U; Wünsch L; Hiort O
Sex Dev; 2017; 11(4):171-174. PubMed ID: 28719904
[TBL] [Abstract][Full Text] [Related]
19. Bone mineral density and quantitative ultrasound parameters in patients with Klinefelter's syndrome after long-term testosterone substitution.
van den Bergh JP; Hermus AR; Spruyt AI; Sweep CG; Corstens FH; Smals AG
Osteoporos Int; 2001; 12(1):55-62. PubMed ID: 11305084
[TBL] [Abstract][Full Text] [Related]
20. Timing of gonadectomy in adult women with complete androgen insensitivity syndrome (CAIS): patient preferences and clinical evidence.
Deans R; Creighton SM; Liao LM; Conway GS
Clin Endocrinol (Oxf); 2012 Jun; 76(6):894-8. PubMed ID: 22211628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
